[ Back to EurekAlert! ] Public release date: 26-Sep-2013
[ | E-mail Share Share ]

Contact: Rebecca Levine
rlevine@pcf.org
310-570-4727
Prostate Cancer Foundation

Prostate Cancer Foundation announces new urine test for prostate cancer available

Unlike PSA test, is ultra specific for prostate cancer

SANTA MONICA, CA -- A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs. The new test—Mi-Prostate Score (MiPS)—improves the utility of the PSA blood test, increases physicians' ability to pick out high-risk prostate tumors from low-risk tumors in patients, and may help tens of thousands of men avoid unnecessary biopsies.

The MiPS test incorporates blood PSA levels and two molecular RNA markers specific for prostate cancer in one final score that provides men and their doctors with a personalized prostate-cancer risk assessment.

Drawbacks of stand-alone PSA testing for prostate cancer

Improving upon the PSA test

An ultra-specific test for prostate cancer

###

For additional research results of the MiPS test, how results will be presented to men and their doctors, and other background information, click here.

From more information on how to send a specimen, please call MLabs at 800-862-7284 or visit http://www.mlabs.umich.edu.

The Prostate Cancer Foundation is not endorsing the use of this test or non-use—PCF does not endorse commercial companies or products. The Foundation heartily applauds each research step made toward precision medicine and better biomarkers for prostate cancer that improves the standard of care for patients and leads to less suffering and death from this disease that will affect one in six men in the US. The Safeway Foundation generously provided unrestricted funding to the Prostate Cancer Foundation for biomarker research that funded this work. The Safeway Foundation also provided PCF-Young Investigator funding to Dr. Tomlins. The Prostate Cancer Foundation is the world's largest philanthropic source of support for accelerating the most promising research for better treatments and cures for prostate cancer. To learn more about PCF go to http://www.pcf.org.



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.